28.04.2011 • News

Merck & Co to Buy Back Up To $5 Billion Of Its Shares

Merck & Co said on Wednesday it plans to buy back up to $5 billion in shares, bringing its total share buyback program to $6.4 billion.
The Whitehouse Station, New Jersey-based drugmaker said the stock purchase has no time limit and will be made on the open market, in block transactions or privately negotiated transactions.

"Merck has a history of leadership in returning cash to shareholders," said Kenneth Frazier, Merck's chief executive officer. "Today's action reflects our confidence in Merck's strategy and demonstrates our commitment to delivering shareholder value."

The company still has $1.4 billion remaining from a share repurchase authorization announced in November 2009.

Company

Logo:

Merck & Co

126 East Lincoln Avenue
07065 Rahway
US

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

most read